ANTI-VIRAL FACTORS IN HUMAN MILK
母乳中的抗病毒因子
基本信息
- 批准号:2201707
- 负责人:
- 金额:$ 21.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-05-01 至 1997-04-30
- 项目状态:已结题
- 来源:
- 关键词:Rotavirus affinity chromatography animal tissue antiviral agents biological products chemical stability developmental nutrition disease /disorder model drug resistance epitope mapping gastroenteritis glycoproteins human milk human tissue ion exchange chromatography laboratory mouse mucins nutrition related tag oligosaccharides protein purification tissue resource /registry virion
项目摘要
Gastrointestinal diseases caused by rotaviruses and related agents
constitute serious health problems for children living in the United
States and other areas of the world. Breast feeding has been identified
as a major factor in decreasing the morbidity and mortality associated
with acute diarrheal disease; however the mechanisms associated with this
protection have not been fully elucidated.
We have identified a macromolecular component of the human milk fat
globule which inhibits the replication of a wide range of rotavirus
strains. The anti-viral activity is associated with acidic glycoprotein
fractions which do not contain immunoglobulins. Reactivity with
monoclonal antibodies indicates that the active material is a component
of the milk mucin complex and that it exerts its activity by binding to
virions. Studies with an animal model system document that the oral
administration of the milk-derived glycoprotein can prevent the
development of rotavirus gastroenteritis.
We propose a series of experiments to purify and characterize the
anti-viral component of human milk. We will determine the
oligosaccharide linkages which are essential for anti-viral activity. We
will also define the viral epitopes which are the targets of the mucin
binding. we propose to generate large amounts of the milk-derived
anti-viral factor and determine the stability of the active material
under a range of environmental conditions. These studies may result in
the identification of a novel anti-viral factor in human milk and in the
subsequent development of a new therapeutic modality for the prevention
and treatment of viral gastroenteritis.
轮状病毒及相关病原体引起的胃肠道疾病
对居住在美国的儿童构成严重的健康问题
各州和世界其他地区。 已确定母乳喂养
是降低相关发病率和死亡率的一个主要因素
患有急性腹泻病;然而与此相关的机制
保护尚未完全阐明。
我们已经鉴定出人乳脂肪的大分子成分
抑制多种轮状病毒复制的小球
菌株。 抗病毒活性与酸性糖蛋白有关
不含免疫球蛋白的级分。 反应性与
单克隆抗体表明活性物质是一种成分
乳粘蛋白复合物,它通过结合来发挥其活性
病毒体。 动物模型系统研究表明,口腔
给予乳源性糖蛋白可以预防
轮状病毒胃肠炎的发展。
我们提出了一系列实验来纯化和表征
母乳中的抗病毒成分。 我们将确定
寡糖连接对于抗病毒活性至关重要。 我们
还将定义作为粘蛋白目标的病毒表位
绑定。我们建议生产大量的牛奶衍生产品
抗病毒因子并测定活性物质的稳定性
在一系列环境条件下。 这些研究可能会导致
在母乳和牛奶中鉴定出一种新型抗病毒因子
随后开发了一种新的预防治疗方法
以及病毒性胃肠炎的治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT H YOLKEN其他文献
ROBERT H YOLKEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT H YOLKEN', 18)}}的其他基金
AMPLIFIED NUCLEIC ACID-EIA FOR MICROBIAL DIAGNOSIS
用于微生物诊断的扩增核酸-EIA
- 批准号:
3547660 - 财政年份:1990
- 资助金额:
$ 21.07万 - 项目类别:
AMPLIFIED NUCLEIC ACID-EIA FOR MICROBIAL DIAGNOSIS
用于微生物诊断的扩增核酸-EIA
- 批准号:
3547663 - 财政年份:1990
- 资助金额:
$ 21.07万 - 项目类别:
AMPLIFIED NUCLEIC ACID-EIA FOR MICROBIAL DIAGNOSIS
用于微生物诊断的扩增核酸-EIA
- 批准号:
3547661 - 财政年份:1990
- 资助金额:
$ 21.07万 - 项目类别:
AMPLIFIED NUCLEIC ACID-EIA FOR MICROBIAL DIAGNOSIS
用于微生物诊断的扩增核酸-EIA
- 批准号:
3547662 - 财政年份:1990
- 资助金额:
$ 21.07万 - 项目类别:
AMPLIFIED NUCLEIC ACID-EIA FOR MICROBIAL DIAGNOSIS
用于微生物诊断的扩增核酸-EIA
- 批准号:
2065609 - 财政年份:1990
- 资助金额:
$ 21.07万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 21.07万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 21.07万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 21.07万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 21.07万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 21.07万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 21.07万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 21.07万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 21.07万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 21.07万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 21.07万 - 项目类别:
Collaborative Research and Development Grants